This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
RITUXIMAB (marketed as Rituxan): progressive multifocal leukoencephalopathy (PML). FDA Drug Safety Newsletter 1: 3-5, No. 1, 2007 - USA
About this article
Cite this article
Rituximab. React. Wkly. 1175, 21 (2007). https://doi.org/10.2165/00128415-200711750-00073
- Multiple Sclerosis
- Progressive Multifocal Leukoencephalopathy
- Occipital Lobe